Friday, July 10, 2026

pharma · Acquired Blepharoptosis · Diabetic Macular Edema

Santen Oy

Santen Oy trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

TAMPERE, FI HQ
15 Employees
EMA registrant Type
Company details
Status
Public
HQ
TAMPERE, FI
Employees
15
Programs
3
Drugs
8
Patents
0
Intelligence · Clinical Trials

Santen Oy clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to Santen Oy programs — each row shows trial ID, program name, phase, status, and indication.

Santen Oy trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for Santen Oy.

  1. 101380003SA — Phase 3

    Clinical update
  2. 101090401IN — Phase 2

    Clinical update
  3. Betamethasone Microsphere (DE-102) Low Dose — Phase 3

    Clinical update

Trial registry

3 studies